Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Short-term Investments: 2014-2020

Historic Short-term Investments for Fortress Biotech (FBIO) over the last 5 years, with Dec 2020 value amounting to $76.8 million.

  • Fortress Biotech's Short-term Investments rose 412.00% to $76.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $76.8 million, marking a year-over-year increase of 412.00%. This contributed to the annual value of $76.8 million for FY2020, which is 412.00% up from last year.
  • Fortress Biotech's Short-term Investments amounted to $76.8 million in FY2020, which was up 412.00% from $15.0 million recorded in FY2019.
  • In the past 5 years, Fortress Biotech's Short-term Investments registered a high of $76.8 million during FY2020, and its lowest value of $15.0 million during FY2019.
  • In the last 3 years, Fortress Biotech's Short-term Investments had a median value of $17.6 million in 2018 and averaged $36.5 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 51.10% in 2018, then skyrocketed by 412.00% in 2020.
  • Yearly analysis of 4 years shows Fortress Biotech's Short-term Investments stood at $36.0 million in 2017, then tumbled by 51.10% to $17.6 million in 2018, then fell by 14.79% to $15.0 million in 2019, then surged by 412.00% to $76.8 million in 2020.